Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary STEVEN GROSSMAN 2/13/21 Analysis and Commentary STEVEN GROSSMAN 2/13/21 FDA-related Provision of House Reconciliation Bill Read More Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More Analysis and Commentary STEVEN GROSSMAN 12/10/20 Analysis and Commentary STEVEN GROSSMAN 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More Analysis and Commentary STEVEN GROSSMAN 10/9/20 Analysis and Commentary STEVEN GROSSMAN 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Party Platforms Don’t Matter, Probably Read More Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Advocacy at a Glance STEVEN GROSSMAN 7/18/20 Advocacy at a Glance STEVEN GROSSMAN 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More Analysis and Commentary STEVEN GROSSMAN 7/10/20 Analysis and Commentary STEVEN GROSSMAN 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary STEVEN GROSSMAN 2/13/21 Analysis and Commentary STEVEN GROSSMAN 2/13/21 FDA-related Provision of House Reconciliation Bill Read More
Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More
Analysis and Commentary STEVEN GROSSMAN 12/10/20 Analysis and Commentary STEVEN GROSSMAN 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More
Analysis and Commentary STEVEN GROSSMAN 10/9/20 Analysis and Commentary STEVEN GROSSMAN 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More
Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More
Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Advocacy at a Glance STEVEN GROSSMAN 8/14/20 Party Platforms Don’t Matter, Probably Read More
Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Advocacy at a Glance STEVEN GROSSMAN 7/18/20 Advocacy at a Glance STEVEN GROSSMAN 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More
Analysis and Commentary STEVEN GROSSMAN 7/10/20 Analysis and Commentary STEVEN GROSSMAN 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Advocacy at a Glance STEVEN GROSSMAN 6/19/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
